Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Etavopivat low dose's trials
HIBISCUS
A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)
Etavopivat Tablets Low dose
Ongoing
Active not recruiting
Phase 3
Open NCT04624659 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
